480 related articles for article (PubMed ID: 23838047)
21. Favipiravir (T-705) protects against Nipah virus infection in the hamster model.
Dawes BE; Kalveram B; Ikegami T; Juelich T; Smith JK; Zhang L; Park A; Lee B; Komeno T; Furuta Y; Freiberg AN
Sci Rep; 2018 May; 8(1):7604. PubMed ID: 29765101
[TBL] [Abstract][Full Text] [Related]
22. Nipah and Hendra Virus Glycoproteins Induce Comparable Homologous but Distinct Heterologous Fusion Phenotypes.
Bradel-Tretheway BG; Zamora JLR; Stone JA; Liu Q; Li J; Aguilar HC
J Virol; 2019 Jul; 93(13):. PubMed ID: 30971473
[TBL] [Abstract][Full Text] [Related]
23. Henipavirus Immune Evasion and Pathogenesis Mechanisms: Lessons Learnt from Natural Infection and Animal Models.
Lawrence P; Escudero-Pérez B
Viruses; 2022 Apr; 14(5):. PubMed ID: 35632678
[TBL] [Abstract][Full Text] [Related]
24. Prefusion stabilization of the Hendra and Langya virus F proteins.
Byrne PO; Blade EG; Fisher BE; Ambrozak DR; Ramamohan AR; Graham BS; Loomis RJ; McLellan JS
J Virol; 2024 Feb; 98(2):e0137223. PubMed ID: 38214525
[TBL] [Abstract][Full Text] [Related]
25. An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections.
Dang HV; Chan YP; Park YJ; Snijder J; Da Silva SC; Vu B; Yan L; Feng YR; Rockx B; Geisbert TW; Mire CE; Broder CC; Veesler D
Nat Struct Mol Biol; 2019 Oct; 26(10):980-987. PubMed ID: 31570878
[TBL] [Abstract][Full Text] [Related]
26. Containing the contagion: treating the virus that inspired the film.
Lee B
Sci Transl Med; 2011 Oct; 3(105):105fs6. PubMed ID: 22013121
[TBL] [Abstract][Full Text] [Related]
27. [Nipah and Hendra virus infectious diseases].
Yoneda M
Nihon Rinsho; 2016 Dec; 74(12):1973-1978. PubMed ID: 30550652
[TBL] [Abstract][Full Text] [Related]
28. Detailed Molecular Biochemistry for Novel Therapeutic Design Against Nipah and Hendra Virus: A Systematic Review.
Bhattacharya S; Dhar S; Banerjee A; Ray S
Curr Mol Pharmacol; 2020; 13(2):108-125. PubMed ID: 31657692
[TBL] [Abstract][Full Text] [Related]
29. A single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters.
van Doremalen N; Lambe T; Sebastian S; Bushmaker T; Fischer R; Feldmann F; Haddock E; Letko M; Avanzato VA; Rissanen I; LaCasse R; Scott D; Bowden TA; Gilbert S; Munster V
PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007462. PubMed ID: 31170144
[TBL] [Abstract][Full Text] [Related]
30. Use of monoclonal antibodies against Hendra and Nipah viruses in an antigen capture ELISA.
Chiang CF; Lo MK; Rota PA; Spiropoulou CF; Rollin PE
Virol J; 2010 Jun; 7():115. PubMed ID: 20525276
[TBL] [Abstract][Full Text] [Related]
31. A highly effective ferritin-based divalent nanoparticle vaccine shields Syrian hamsters against lethal Nipah virus.
Yin C; Yao YF; Yang P; Liu H; Gao G; Peng Y; Chen M; Lu M; Zhang X; Guo W; Zhang Z; Hu X; Yuan Z; Shan C
Front Immunol; 2024; 15():1387811. PubMed ID: 38911870
[TBL] [Abstract][Full Text] [Related]
32. Transcriptome Profiling of the Virus-Induced Innate Immune Response in Pteropus vampyrus and Its Attenuation by Nipah Virus Interferon Antagonist Functions.
Glennon NB; Jabado O; Lo MK; Shaw ML
J Virol; 2015 Aug; 89(15):7550-66. PubMed ID: 25972557
[TBL] [Abstract][Full Text] [Related]
33. Resistance of Cynomolgus Monkeys to Nipah and Hendra Virus Disease Is Associated With Cell-Mediated and Humoral Immunity.
Prasad AN; Woolsey C; Geisbert JB; Agans KN; Borisevich V; Deer DJ; Mire CE; Cross RW; Fenton KA; Broder CC; Geisbert TW
J Infect Dis; 2020 May; 221(Suppl 4):S436-S447. PubMed ID: 32022850
[TBL] [Abstract][Full Text] [Related]
34. Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins.
Dang HV; Cross RW; Borisevich V; Bornholdt ZA; West BR; Chan YP; Mire CE; Da Silva SC; Dimitrov AS; Yan L; Amaya M; Navaratnarajah CK; Zeitlin L; Geisbert TW; Broder CC; Veesler D
Nat Struct Mol Biol; 2021 May; 28(5):426-434. PubMed ID: 33927387
[TBL] [Abstract][Full Text] [Related]
35. Vaccination of ferrets with a recombinant G glycoprotein subunit vaccine provides protection against Nipah virus disease for over 12 months.
Pallister JA; Klein R; Arkinstall R; Haining J; Long F; White JR; Payne J; Feng YR; Wang LF; Broder CC; Middleton D
Virol J; 2013 Jul; 10():237. PubMed ID: 23867060
[TBL] [Abstract][Full Text] [Related]
36. The changing face of the henipaviruses.
Croser EL; Marsh GA
Vet Microbiol; 2013 Nov; 167(1-2):151-8. PubMed ID: 23993256
[TBL] [Abstract][Full Text] [Related]
37. A Cross-Reactive Humanized Monoclonal Antibody Targeting Fusion Glycoprotein Function Protects Ferrets Against Lethal Nipah Virus and Hendra Virus Infection.
Mire CE; Chan YP; Borisevich V; Cross RW; Yan L; Agans KN; Dang HV; Veesler D; Fenton KA; Geisbert TW; Broder CC
J Infect Dis; 2020 May; 221(Suppl 4):S471-S479. PubMed ID: 31686101
[TBL] [Abstract][Full Text] [Related]
38. Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infection.
Yun T; Park A; Hill TE; Pernet O; Beaty SM; Juelich TL; Smith JK; Zhang L; Wang YE; Vigant F; Gao J; Wu P; Lee B; Freiberg AN
J Virol; 2015 Jan; 89(2):1242-53. PubMed ID: 25392218
[TBL] [Abstract][Full Text] [Related]
39. Heparan sulfate-dependent enhancement of henipavirus infection.
Mathieu C; Dhondt KP; Châlons M; Mély S; Raoul H; Negre D; Cosset FL; Gerlier D; Vivès RR; Horvat B
mBio; 2015 Mar; 6(2):e02427. PubMed ID: 25759505
[TBL] [Abstract][Full Text] [Related]
40. Fc-Based Recombinant Henipavirus Vaccines Elicit Broad Neutralizing Antibody Responses in Mice.
Li Y; Li R; Wang M; Liu Y; Yin Y; Zai X; Song X; Chen Y; Xu J; Chen W
Viruses; 2020 Apr; 12(4):. PubMed ID: 32340278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
